Medical News

RSS

Hybrid scanner helps to enhance visibility of skin cancer cells

Scientists are reporting development of a substance to enhance the visibility of skin cancer cells during scans with an advanced medical imaging system that combines ultrasound and light. The hybrid scanner could enable doctors to detect melanoma, the most serious form of skin cancer, in its earliest and most curable stages, the report in the monthly journal ACS Nano indicates.

12 Aug 2010

American Medical Alert second-quarter net income increases 30% to $791,418

American Medical Alert Corp.a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and six months ended June 30, 2010.

12 Aug 2010

MedThink Connect Web online communications tool enables face-to-face interaction with experts

MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.

12 Aug 2010

Oral sex becomes common activity among young women: Study

University of Alberta researcher Brea Malacad says results from a study on oral sex indicate there is little doubt that oral sex is becoming a more common activity for young women. Study results show the act has become a fundamental part of what Malacad calls the "sexual revolution of the 21st century". And she concludes that researchers, sex educators and marketers of safer-sex paraphernalia need to catch up with the trend.

12 Aug 2010

States consider how best to spend extra Medicaid funds

In light of the $26 billion aid package passed by Congress Tuesday, states are considering their next steps.

12 Aug 2010

Secret of building muscle using light weights

Current gym dogma holds that to build muscle size you need to lift heavy weights. However, a new study conducted at McMaster University has shown that a similar degree of muscle building can be achieved by using lighter weights. The secret is to pump iron until you reach muscle fatigue.

12 Aug 2010

Research identifies abnormal huntingtin protein critical for mitosis and cell fate determination

New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.

12 Aug 2010

Syndax raises $6 million to support ENCORE 301 study in breast cancer

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that it has issued $6M in convertible notes and warrants to its Series A investors bringing the total investment to date to $55M. All current investors, including Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures, Pappas Ventures and MC Life Sciences participated in the securities offering.

12 Aug 2010

Merging hospitals irk locals in Boston, Orlando

Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.

12 Aug 2010

University of Maryland receives grant from NCRR to acquire superconducting NMR spectrometer

The University of Maryland, in partnership with the University of Maryland, Baltimore and University of Maryland Baltimore County, has received a $7.9 million federal grant to acquire a superconducting 950 MHz Nuclear Magnetic Resonance (NMR) magnet that will help researchers unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

12 Aug 2010

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the Schepens Eye Research Institute, a charitable corporation of Massachusetts and an affiliate of Harvard Medical School.

12 Aug 2010

Scientists find therapeutic potential of stem cells for acute lung injury

Researchers are reporting this week new study results they say provide further evidence of the therapeutic potential of stem cells derived from bone marrow for patients suffering from acute lung injury, one of the most common causes of respiratory failure in intensive care units.

12 Aug 2010

K-State researcher receives grant from NIH to continue cancer research

Understanding how cancer cells communicate with each other and how to enhance their receptiveness to drug treatments is the focus of promising work by a Kansas State University researcher.Annelise Nguyen, assistant professor of toxicology in the department of diagnostic medicine and pathobiology at K-State's College of Veterinary Medicine, recently received a $370,000 grant from the National Institutes of Health to continue her cancer research.

12 Aug 2010

More Medicare Part D checks in the mail

The Department of Health and Human Services has mailed out a third round of $250 checks to help seniors who enter the Medicare Part D coverage pay gap for prescription drugs, WCAX [in Vermont] reports. "The one-time payment aims to close a gap in coverage for prescription medication. The rebates will go to about 9,000 Vermonters whose out-of-pocket expenses already total more than $940 for the year" (8/11).

12 Aug 2010

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.

12 Aug 2010

Scientists develop new metabolite analysis technique for accurate ovarian cancer detection

Scientists at the Georgia Institute of Technology have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a single drop of blood serum, the test correctly identified women with ovarian cancer in 100 percent of the patients tested. The results can be found online in the journal Cancer Epidemiology, Biomarkers, & Prevention Research.

12 Aug 2010

Augmenix announces commercial implantation of SpaceOAR absorbable spacer system for radiation treatment

Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company's CE Mark approved SpaceOAR System. The SpaceOAR hydrogel (from spacing Organs At Risk) is designed to be a tissue compatible, absorbable spacer to reduce radiation injury to healthy tissues.

12 Aug 2010

Venom-based nanoparticles improve gene therapy for fighting glioma

An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes - genes that treat disease - to reach more brain cancer cells than current approaches, according to the study in ACS Nano, a monthly journal.

12 Aug 2010

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Isotechnika Pharma Inc. today announced financial results for the second quarter ended June 30, 2010.

12 Aug 2010

Einstein College receives grant to develop stem cell-based therapies

Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome - part of acute radiation syndrome (ARS) - for military personnel, first responders and the general public. The Einstein research, funded by the federal Centers for Medical Countermeasures Against Radiation, is part of a program coordinated by the National Institute of Allergy and Infectious Diseases.

12 Aug 2010

Medical News

Hybrid scanner helps to enhance visibility of skin cancer cells

American Medical Alert second-quarter net income increases 30% to $791,418

MedThink Connect Web online communications tool enables face-to-face interaction with experts

Oral sex becomes common activity among young women: Study

States consider how best to spend extra Medicaid funds

Secret of building muscle using light weights

Research identifies abnormal huntingtin protein critical for mitosis and cell fate determination

Syndax raises $6 million to support ENCORE 301 study in breast cancer

Merging hospitals irk locals in Boston, Orlando

University of Maryland receives grant from NCRR to acquire superconducting NMR spectrometer

NeoStem, Schepens Eye Research Institute collaborate to develop therapies for AMD and Glaucoma

Scientists find therapeutic potential of stem cells for acute lung injury

K-State researcher receives grant from NIH to continue cancer research

More Medicare Part D checks in the mail

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Scientists develop new metabolite analysis technique for accurate ovarian cancer detection

Augmenix announces commercial implantation of SpaceOAR absorbable spacer system for radiation treatment

Venom-based nanoparticles improve gene therapy for fighting glioma

Isotechnika second-quarter revenue from continuing operations increases to $1.49 million

Einstein College receives grant to develop stem cell-based therapies

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News